Michał Petelenz

Michał Petelenz

Auto-generated profile, based on publicly available information

Michał Petelenz

Medical University of Silesia in Katowice, School of Pharmacy with the Division of Laboratory Medicine in Sosnowiec, Department of Basic Biomedical Science, Kasztanowa Street 3, Sosnowiec 41-200, Poland

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2005 in Anesthesiology
Verified
Journal Article
Closed access
PJPrzemysław Olaf Jałowiecki
Przemysław Olaf Jałowiecki
RRRobert Rudner
Robert Rudner
MGMaciej Gonciarz
Maciej Gonciarz
PKPiotr Kawecki
Piotr Kawecki
MPMichal Petelenz
Michal Petelenz
PDPiotr Dziurdzik
Piotr Dziurdzik
Background: This study evaluated the ability of dexmedetomidine to provide analgesia and sedation for outpatient colonoscopy, examining outcomes including cardiorespiratory variables, side effects, and discharge readiness. Methods: Sixty-four patients were randomly assigned to one of three treatment regimens. In group D, patients received 1 microg/kg dexmedetomidine over 15 min followed by an infusion of 0.2 microg x kg x h. Group P received meperidine (1 mg/kg) with midazolam (0.05 mg/kg), and group F received fentanyl (0.1-0.2 mg intravenous) on demand. The assessment included measurements of heart rate, blood pressure, oxygen saturation, respiratory rate, quality of sedation/analgesia, and an evaluation of the recovery time. Results: The study was terminated before the planned 90 patients had been recruited because of adverse events in group D. In all groups, negligible hemoglobin oxygen saturation and respiratory rate variations were observed. In group D, there was a significantly larger decrease in heart rate (to approximately 40 beats/min in 2 of 19 cases) and blood pressure (to less than 50% of the initial value in 4 of 19 patients). Supplemental fentanyl was required in 47% of patients receiving dexmedetomidine to achieve a satisfactory level of analgesia (vs. 42.8% of patients in group P and 79.2% of patients in group F). Vertigo (5 patients), nausea/vomiting (5 patients), and ventricular bigeminy (1 patient) were observed only in group D. Time to home readiness was longest in group D (85 +/- 74, 39 +/- 21, and 32 +/- 13 min in groups D, P and F, respectively; P = 0.007). Conclusions: The use of dexmedetomidine to provide analgesia/sedation for colonoscopy is limited by distressing side effects, pronounced hemodynamic instability, prolonged recovery, and a complicated administration regimen.

1 May 2003 in Gastrointestinal Endoscopy
Verified
Journal Article
Closed access
RRRobert Rudner
Robert Rudner
PJPrzemysław Olaf Jałowiecki
Przemysław Olaf Jałowiecki
PKPiotr Kawecki
Piotr Kawecki
MGMaciej Gonciarz
Maciej Gonciarz
AMAldona Mularczyk
Aldona Mularczyk
MPMichal Petelenz
Michal Petelenz

1 December 2012 in European Journal of Gastroenterology & Hepatology
Verified
Journal Article
Closed access
JMJoanna Musialik
Joanna Musialik
WSWanda Suchecka
Wanda Suchecka
EKEwa Klimacka-Nawrot
Ewa Klimacka-Nawrot
MPMichał Petelenz
Michał Petelenz
Magdalena Hartman-PetryckaMagdalena Hartman-Petrycka
Magdalena Hartman-Petrycka
BBBarbara Błońska-Fajfrowska
Barbara Błońska-Fajfrowska
Objective Decreased appetite is one of the main factors that influences quality of life of patients with chronic liver diseases. The reason for appetite disorders remains unclear but taste perturbations are one of the postulated causes. The potential role of taste alterations and, connected to these, appetite disorders in chronic hepatitis C (CHC) patients are poorly investigated. The aim of this study was to evaluate potential taste alterations (dysgeusia) including all five tastes (sweet, salty, bitter, sour and umami) in CHC patients. Methods Forty CHC patients (16 men and 24 women) infected with genotype 1 hepatitis C virus participated in this study. All the patients had a compensated liver disease and were being treated with any agents. One hundred and ten healthy volunteers were matched to the patients by age and sex. The study included gustatory tests (taste recognition threshold, taste intensity with hedonic perception) and analysis of the pleasure derived from eating. Results In CHC patients, the recognition threshold of umami taste was increased (P<0.01) and the intensity of sweet taste perception was higher (P<0.05). The hedonic response did not differ between the groups. A significant increase in declared pleasure derived from eating (P<0.001 to P<0.05) was also observed. Some differences in case of the patients with more advanced disease were also found. Conclusion Alterations in taste, especially umami and sweet taste disorders, may alter real food perception and lead to a reduction in food intake in some CHC patients.

1 November 2009 in Pathology - Research and Practice
Verified
Journal Article
Closed access
AGAndrzej Gabriel
Andrzej Gabriel
Michael KuklaMichael Kukla
Michael Kukla
MWMariusz Wilk
Mariusz Wilk
ŁLŁukasz Liszka
Łukasz Liszka
MPMichał Petelenz
Michał Petelenz
JMJoanna Musialik
Joanna Musialik

1 February 2017 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
SWS. Wilczyńki
S. Wilczyńki
MPM. Petelenz
M. Petelenz
MFMałgorzata Florek-Wojciechowska
Małgorzata Florek-Wojciechowska
SKSławomir Kulesza
Sławomir Kulesza
SBSz. Brym
Sz. Brym
DKDanuta Kruk
Danuta Kruk

17 June 2004 in Endoscopy
Verified
Journal Article
Closed access
PDF file
MPM. Petelenz
M. Petelenz
MGM. Gonciarz
M. Gonciarz
PMP. Macfarlane
P. Macfarlane
RRR. Rudner
R. Rudner
PKP. Kawecki
P. Kawecki
ZGZ. Gonciarz
Z. Gonciarz
Background and Study Aim: Colonoscopy is a common gastroenterological procedure for investigation of the bowel. The main side effects of colonoscopy are pain during investigation, cardiovascular complications and very rarely even death. The aim of this study was to compare the continuous fluctuation of heart rate variability (HRV) components during colonoscopy under normal conditions, analgesia/sedation, and total intravenous anesthesia. Patients and Methods: 37 consecutive patients (aged 35 - 65), were randomly allocated to three groups: no sedation (control group 1); analgesia/sedation (group 2); and total intravenous anesthesia (group 3). Holter electrocardiography and subsequent frequency domain analysis were undertaken. The low-frequency (LF, 0.04 - 0.15Hz) and the high-frequency (HF, 0.15 - 0.40Hz) components were estimated using spectral analysis in the usual way. Normalized units (nu) were calculated from the following equations: LFnu = LF/(LF + HF), and HFnu = HF/(LF + HF). Results: Groups 2 and 3 were found to have a significantly lower HFnu and higher LFnu than group 1 essentially throughout the procedure. A one-way analysis of variance and t-test confirmed that the differences were significant when the colonoscope reached the splenic flexure as were the LF/HF balances at the splenic and hepatic flexures and the cecum. The percentage change in LF/HF was also analyzed, and it was found that in group 3 the mean change was over 136 % when the colonoscope reached the sigmoid flexure, which was significantly higher than in the other two groups. Conclusion: Most changes in HRV components occurred during colonoscopy of the left side of the bowel. Analgesia/sedation and total intravenous anesthesia increased HRV by increasing the LF component.